Organon (OGN) Payables (2020 - 2026)
Organon (OGN) posted quarterly Payables of $1.1 billion for Q2 2026, down 1.5% year-over-year from $1.1 billion in Q2 2025, and up 6.92% on a QoQ basis from $983.0 million in Q1 2026.
Organon (OGN) Payables (2020 - 2026) Analysis & Trends
Organon has reported Payables for 7 years, with the latest figure at $1.1 billion in Q2 2026.
- Payables for Q2 2026 came in at $1.1 billion, down 1.5% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.1 billion (down 1.5% YoY), and the FY2025 annual result was $952.0 million, down 18.35% from the prior year.
- Payables rose to $1.1 billion in Q2 2026, from $983.0 million in the prior quarter.
- Over five years, Payables peaked at $1.3 billion in Q4 2023 and troughed at $952.0 million in Q4 2025.
- A 5-year average of $1.1 billion and a median of $1.1 billion in 2023 frame the typical range for Payables.
- The largest YoY upside for Payables was 309.47% in 2022 against a maximum downside of 38.55% in 2022.
- A 5-year view of Payables shows it stood at $1.1 billion in 2022, then increased by 17.49% to $1.3 billion in 2023, then declined by 12.33% to $1.2 billion in 2024, then dropped by 18.35% to $952.0 million in 2025, then rose by 10.4% to $1.1 billion in 2026.
- Per Business Quant data, the three most recent Payables figures were $1.1 billion in Q2 2026, $983.0 million in Q1 2026, and $952.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 22.89 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -25.00 Bn |
| 10 | Organon | 3.61 Bn | 2.48 Bn | 847.00 Mn | 1.05 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.05 Bn |
| Mar 31, 2026 | 983.00 Mn |
| Dec 31, 2025 | 952.00 Mn |
| Sep 30, 2025 | 1.07 Bn |
| Jun 30, 2025 | 1.07 Bn |
| Mar 31, 2025 | 1.01 Bn |
| Dec 31, 2024 | 1.17 Bn |
| Sep 30, 2024 | 1.09 Bn |
| Jun 30, 2024 | 1.24 Bn |
| Mar 31, 2024 | 955.00 Mn |
| Dec 31, 2023 | 1.33 Bn |
| Sep 30, 2023 | 1.07 Bn |
| Jun 30, 2023 | 1.12 Bn |
| Mar 31, 2023 | 996.00 Mn |
| Dec 31, 2022 | 1.13 Bn |
| Sep 30, 2022 | 1.03 Bn |
| Jun 30, 2022 | 1.13 Bn |
| Mar 31, 2022 | 1.08 Bn |
| Dec 31, 2021 | 1.38 Bn |
| Sep 30, 2021 | 1.67 Bn |